Introduction
The term of brachytherapy, also known as "internal radiotherapy, sealed source radiotherapy, curietherapy or endocurietherapy" is from Greek work brachy means short distance and therapy (treatment) and also known as internal radiotherapy or sealed source radiotherapy. Brachytherapy is a special form of radiotherapy where a radioactive source is carefully placed on or inside the area to be treated. Brachytherapy sources are usually encapsulated; they can be used within the body cavities close to the tumor, placed in a lumen of organs, implanted in to the tumor or placed over the tissue to be treated. The main purpose in radiation therapy is controlling disease and reducing side effects. For a good clinical result one must assure the dose concentrate in the tumor mass and surrounding volume which is at risk of the tumor micro-extensions, while minimizing radiation received by the normal tissue. This can be verified by experimental measurement which is the base of Brachytherapy dosimetry. Due to the high dose gradient near the source and low signal to noise ratio at great distances, experimental dosimetry in Brachytherapy is very complicated or even in small distances is impossible. Also the dose variation with angle in 4 geometry of the source must be considered, since routine experimental measurement does not represent this. One of the widely used techniques for solving this problem is Monte Carlo simulation of radiation transport. The calculation of dose distributions at small distances and also validation of experimental measurement can be done by one of the powerful codes such as MCNP, BEAM, EGSnrc, PENELOPE, GEANT4, and ETRAN/ITS. One of the important parameters in the calculation process is validation of the Monte Carlo calculations with measurement results. This chapter starts with an introduction lecture about brachytherapy history and a short review of the different models for sealed Brachytherapy sources. A brief discuss of brachytherapy dosimetry with computer and measurement is provided. In 1995 the American Association of Physicists in Medicine (AAPM) Task Group No. 43 published a protocol including new formalism for brachytherapy dose calculation and updated in 2004 as TG-43U1. The concept of AAPM recommendation and TG 43 formalism are introduced. Application of Monte Carlo in simulation, guideline for Monte Carlo dosimetry, calculation methodology, requirement for simulation and validation of calculation are then outlined. A short overview of other application of Monte Carlo in brachytherapy such as eye plaque and applicator design, evaluation of treatment planning system calculation is described. Finally an example of Monte Carlo calculations for dosimetric parameters of 103 Pd brachytherapy seed in three geometric models based on different location of beads inside the capsule is provided.
History
The use of radioactive sources for treatment of cancerous tumours started shortly after the discovery of radium ( 226 Ra) in 1898 by Madame Curie. This was followed in 1901 by Pierre Curie's self exposure experiment. Brachytherapy developed largely through the use of sealed radium and radon sources, but, quantities and forms of radioactivity useful for brachytherapy were not available until 1940s, when civilian applications of nuclear reactors were encouraged. In 1950s Radium-226 tubes with 1 mm Pt filtration remained the dominant intracavitary source through the late 1960s. Due to the revolutionary of all radiotherapy developments like beam therapy a n d n e ed o f e x p e r i e n c e t o p o s i t i o n t h e brachytherapy sources with sufficient accuracy and radiation exposure hazards for personnel, the role of brachytherapy was not secure in that era. However, over the past three decades, there has been renewed interest in the use of brachytherapy for a number of reasons. The discovery of man-made radioisotopes and remote afterloading techniques has reduced radiation exposure hazards. Newer imaging techniques (CT scan, magnetic resonance imaging, ultrasound) and computerized treatment planning has helped to achieve good clinical outcomes. The advantages of brachytherapy to surgery are treatment simplicity, minimum damage to the surrounding normal tissues and the reduction of side effects for patient after treatment. The advantages of brachytherapy to tele-therapy are its ability in radiation localization on tumor tissue, minimizing radiation to the surrounding normal tissues and rapid dose reduction in normal tissues surrounding the tumor ). 226Ra sealed in platinum tubes or needles, was the first radionuclide used in brachytherapy treatments. Radium has the advantage of a very long half-life (1620 years), but it also has the disadvantage of producing the alpha-emitting gaseous daughter product radon. 222 Rn, the daughter product of 226 Ra has a half-life of 3.83 days, in a gas form was extracted and sealed within a gold seed, was later used for permanent implants. (Baltas et al., 2007) . By the early 1950s, both 226 Ra and 222 Rn have been replaced by newly developed isotopes and brachytherapy had become a well-established and mature modality (Williamson, 2006) . In 1950s when produced of other nuclides became available, radium and radon replaced with other new produced radionuclides and they are no longer used. Most common brachytherapy sources emit photons; however, in a few specialized situations such as Craniopharyngiomas which are pediatric tumors, accounting for about 6% of all intracranial tumors in children, emitting sources are used (Sadeghi et al., 2009a) . Brachytherapy photon emitter sources are available in various forms (needles, tubes, seeds, wires, pellets) but are generally sealed to provide shielding against the undesired and radiation emitted from the sources and also to prevent leakage. These sources are used in various types of brachytherapy implant. Sources can be place in to the body cavities near to the tumours (intracavitary), trains of sources are loaded within the lumen of organs (interaluminal), sources are implanted within the tumours (interstitial), or a single source is placed into small or large arteries (intravascular). The dose is then delivered continuously, Some physical characteristics of these common brachytherapy sources are summrized in Table 1 . (Ling et al., 1995; Nath et al., 2005; Antipas et al., 2001; Wuu & Zaider, 1998 
Dose distributions around the sources
Dosimetry, as used in brachytherapy, means the methodology of calculating the dose rate value at an interest point from a source in a given medium. It is important that the physicist know the theoretical basic of dose calculation, manually or using a computer algorithm, around the source in adjacent healthy and critical organs. In modern brachytherapy all available sources have a cylindrical geometry, and are fabricated in core and encapsulation form that can assume a cylindrical symmetry of the dose distribution to their longitudinal axis. The base of brachytherapy dosimetry is experimental measurements and any other theoretical calculations must be validated against measured values. But due to the high dose gradient near the source and low signal to noise ratio at great distances, experimental dosimetry in Brachytherapy is very complicated and in small distances has had a higher degree of uncertainty. Calculation the dose in any points and angles is available by theoretical methods. To improve calculation accuracy it is desirable to make use of Monte Carlo method, which is a computational tool that samples from known probability distributions to determine the average behaviour of a system, it is used in medical physics, particularly in brachytherapy to improve our understanding of all processes associated with radiation emission and transport by using random numbers. So Monte Carlo becomes a powerful tool in medical physics applications (Rogers, 2006; Baltas et al., 2007; Calatayud et al., 2009 (Nath et al., 1995; .
The TG-43 formalism
The proposed formula for two-dimensional dose rate is:
Where , is the dose rate in water at the distance r in cm from a line source and denotes the polar angle specifying the point of interest as shown in Figure 1 , is the airkerma strength has unit of , is the dose rate constant expressed in
is the geometry factor; , are the reference position, and 9 , is the radial dose function; and , is the anisotropy function. Fig. 1 . Coordinate system used for brachytherapy dosimetry calculations.
Brachytherapy source strength
Source-strength designation has gone through several changes over the years. The earliest quantity (mass of radium) was commonly referred to by the unit, milligram radium and still is used in some cases. For sealed sources, especially those of low energy, the encapsulation reduces the air kerma and dose rates below those which would be produced by the bare source. Thus the strength is generally given as apparent activity, which is less than the encapsulated activity. Apparent activity is the activity of a hypothetical point source of the same radionuclide which would produce the same air kerma rate, at the same large distance, as that measured on the transverse axis of a sealed source. The design of the source capsule also influences the dose distribution around the source. It is quite possible for two sources of the same radionuclide and same apparent activity to have different dose distributions. (Nath et al., 1997) .
Air-kerma strength,
Air-kerma strength is the product of air-kerma rate in free space at the measured distance from the source centre along the perpendicular bisector, r, multiplied by the square of this distance, r 2 :
Distance r must be chosen large enough, relative to the linear dimension of the source, to find independent air kerma strength of distance. is the air kerma rate in vacuo and for the photons of energy greater than a certain cutoff value of δ which is typically 5 keV for low-energy photon emitting sources . This value is www.intechopen.com dependent on the assumption that photons with energies up to this cut-off value are not tissue penetrating. The qualification ''in vacuo'' means that the measurements should be corrected for photon attenuation and scattering in air and any other medium interposed between the source and detector.
Dose-rate constant, Λ
The dose rate constant, Λ, is defined as the dose rate in water at the reference point, , , namely at a distance of r 0 =1 cm on the transverse axis (θ=90 0 ), per unit air kerma strength, S K , as seen in Equation (3):
The dose rate constant depends on both the radionuclide and source model, and is influenced by both the source design (radioactive distribution and encapsulation) and also the methodology used to determine .
Geometry function,
, The geometry function, G X r, θ , takes into account the effect of the distribution of radioactive material inside the capsule on the dose distribution and is a function of both r and θ. physically it provides an effective inverse square-law and neglects scattering and attenuation of emitting photons around the source (Karaiskos et al., 2000) . The subscript "X" is to indicate a point-source, "P" or line-source, "L", geometry function. The values of the geometry function can then be calculated as follow: t a n sin cos / sin cos /
Where β is the angle in radians, subtended by P(r,θ) and two ends of active length of the source. In the case where radioactive material is distributed over a cylindrical volume, the active length, L, will be the length of the cylinder (Fig.1 ). For brachytherapy sources containing multiple radioactive pellets, L is given by:
Where N is the number of discrete pellets contained in the source, and is the center to center distance of the pellets. The active length should be less than the length of source capsule. In the case where it is greater, the effective length of the seed is considered the distance between proximal and distal aspects of the activity distribution.
Radial dose function,
The radial dose function describes the effect of tissue attenuation on photons emitted from a brachytherapy source and accounts for the dose fall-off along the source transverse axis due to the photon scattering and attenuation. Equation (6) is defined the as:
5.6 2D anisotropy function, , The 2D anisotropy function describes the variation of dose in the longitudinal plane of the seed. Variations are due to the distribution of radioactivity within the seed, self-absorption and oblique filtration of the radiation in the encapsulating material. F r, θ Is obtained by the following formula:
The use of Monte Carlo to obtain the dosimetric parameter
The most important role of Monte Carlo in brachytherapy is to obtain the dosimetric parameters of the sources with high spatial resolution. As mentioned above, "dosimetry" refers to estimation of absorbed dose by means of experimental or fundamental theoretical techniques about single brachytherapy sources. Due to the high dose gradient near the brachytherapy sources at short distances in water or water-equivalent phantoms, near-field dosimetry of brachytherapy sources is very complicated. To avoid dosimeter averaging effects, very high resolution (les than 0.5 mm) dosimeters are required (Chiu-Tsao et al., 2007; Williamson 1991) ; also low energy-response of some detectors; and lake of reproducibility, increase the uncertainty in experimental dosimetry. Monte Carlo simulation is the theoretical method for calculation of dosimetric parameters. Monte Carlo simulation easily can obtain dosimetric parameters at small distances and all angles without any limitation and complication. For low energy photon emitters such as 125 I and 103 Pd, photoelectric absorption contributes a larger proportion of the dose to tissue than for higher energies. Therefore, small variations in tissue atomic number result in significant effects on dose. These effects can also be calculated precisely by Monte Carlo simulation by replacing the different phantom materials in different geometries (Dale et al., 1985; Prasad 1985; Huang 1990 ). According to TG-43U1 recommendation, the main guideline items that should be considered in MC simulation for accurate calculations are as follow: 1. The information of source dimension, composition of encapsulation and internal components and their geometry must be specified clearly; typically these data obtained by manufacturer's report and Monte Carlo allows complete flexible description of the real geometry of the sources. 2. Simulation should be performed in a 30 cm water phantom for low energy photonemitters like 125 I and 103 Pd, and 40 cm water phantom for high energy photon-emitters such as 137 Cs and 192 Ir, to consider all the scattering effects of the surrounding medium. 3. To extract the absorbed dose distribution from the particle transport simulation, one has to define a so-called tally or scoring function. The size and position of scoring voxels (detectors) should define in a way to decrease the uncertainty; usually Monte Carlo uses voxels at radial distances up to 10 cm, for low energy sources and to 15 cm for high energy sources, away from the source at different polar angles. The voxel sizes are an important issue in simulation. To minimize the systematic error, the voxel sizes should be small as low as possible. 4. Enough histories should be calculated to ensure that the statistical uncertainties are in confidence range. 5. The statistical uncertainty should be ≤2% (for r < 5 cm) and ≤1% in with k=1. 6. Due to the lake of old cross-section libraries for low energy photons, modern and new cross-section libraries should be used in Monte Carlo simulation. 7. Mechanical movement of the internal component of the seeds should be considered in the simulation. Because the location of the sources can vary with seed orientations and can affect on dosimetric parameters. To calculate the dosimetric parameters, two simulations are needed: one with the source model in the medium which is usually water phantom, to obtain the dose at interest points; second simulation by modelling in vacuum to obtain the air kerma strength and geometry function. For low energy photon emitters such as 125 I and 103 Pd, the source is modelled in a centre of a 30 cm spherical water phantom, large enough to consider effects of the surrounding medium. For HDR sources like 137 Cs and 192 Ir, the photon energies are higher than those emitted by 125 I and 103 Pd, therefore a 40 cm diameter spherical phantom is considered for modelling (Rivard, 2007; Perez-Calatayud et al., 2004; Melhus and Rivard, 2006) . Generally for low energy photon emitters, is calculated in several air-filled detectors at distances ranging from 5 to 150 cm in the transverse plane in free air geometry, which is found to be independent of distance. Due to the low energy of the photons from the low energy sources, it is assumed in the Monte Carlo calculations all electrons generated by the photon collisions are absorbed locally and the electronic equilibrium exists, so dose is equal to kerma at all points of interest & Sadeghi et al., 2008b . It should be noted that for high energy sources, electronic equilibrium, and consequently, water kerma dose approximation, may be safely assumed only at distances greater than 1 mm from the sources (Wang & Li 2000 , Baltas 2001 ). Geometry function just provides the inverse square low correction depending only on the shape of the active core and not on the encapsulation or radionuclide. Thus the medium inside and around the source has been considered as vacuum in order to disregarded the absorption and scattering in the seed and the surrounding media. The geometry function value is given by Equation (4). For calculating geometry function, the mass densities of all materials within the entire computational geometry should be set equal to zero so there were no interaction and particles streamed through the seed phantom geometry and it is common to approximate the active source material distribution within a brachytherapy source by an idealized geometry such as a line. (Levitt et al. 2006 , Rivard 2001 . To obtain radial dose function values, Monte Carlo method is the best choice. Due to the complication of experimental measurement at small distances, dose rates are estimated down to the smallest distances and experimental values are only consider for validation of the Monte Carlo simulation results. By applying the Equation (6) radial dose function, which is the radial dependence of the dose rate value at the reference polar angle, θ=90º, is obtained and equal to unity at distance 1 cm. Dose rates can be estimated by linear interpolation from data tabulated at discrete points. The tabulated values are fit to polynomial which is proposed in TG-43U1.
www.intechopen.com (8) Parameters to should be calculated by fifth order polynomial fit to the tabulated data within ±2%. Commonly radial distance range for low energy sources is from 0.5 to 7.0 cm and for high energy sources is up to 15.0 cm. Depending on the source encapsulation design, in some cases calculation at distance as low as 0.1 cm could be also needed. The values of the anisotropy function, defined by Equation (7), can be derived from Monte Carlo calculated at different radial distances from r= 0.25 to 7.0 cm for low energy sources and up to 15.0 cm for high energy sources, and different polar angles from θ=0º to 90º for symmetric sources about the transverse plane and from θ=0º to 180º for source design that are asymmetric about the transverse plane. According to Equation (7), the anisotropy function value at any radial distance on transfer plan, is always 1.0. Its value off the transfer plan decreases as: r increases, encapsulation thickness increases, θ approaches 0º or 180º and energy of photon decreases (Bethesda et al., 1985) .
Validation of Monte Carlo modelling
As the Monte Carlo method has its own uncertainties, the preferred general approach is to use other determination method, and compare the results. According to TG-43U1 recommendation and other research publications, it has been accepted as a standard method that validation of Monte Carlo calculations via independent studies is required. To verify the Monte Carlo calculations, the experimental data sets should be compared with calculated data. For the experimental dosimetry in brachytherapy it is necessary to introduce a dosimeter in the radiation field of a source which should provide a measurable reading and present an adequate sensitivity with small sensitive volume to avoid dose volume averaging. The dosimetric system that provides optimum compromise between these prerequisites is TL dosimetry TLDs are currently considered as the dosimeter of choice for experimental dosimetry in the entire energy range of brachytherapy sources and TLD dosimetry is an accepted approach to validate the Monte Carlo simulation. Because the value of dosimetric parameters strongly depends on source material, seed model, encapsulation thickness and geometry, the experimental measurement should be done for the same seed which is modeled in Monte Carlo simulation. The steep dose gradient around low energy radio-nuclides such as 125 I and 103 Pd causes significantly dosimetric uncertainty. So the validation should be done for the larger distances, for example 1-5 cm then all other data especially for small distances, can get from Monte Carlo results. For other sources with higher energy like 137 Cs and 192 Ir, the dependence of dosimetric parameters of source geometry and material is low and measured value can obtain from similar source design. If the Monte Carlo and experimental datasets are compatibles within the acceptable uncertainties, a set of consensus value of dosimetric parameters would be established. The consensus data were defined as the ideal candidate dataset having the highest resolution, covering the largest distance range, and having the highest degree of smoothness. The consensus dose rate constant value should be obtained by the averaged experimental and Monte Carlo Λ values:
Or it should be selected as being representative of the collection of values available in the literature.
The consensus values for anisotropy function and radial dose function for most source models are mostly selected from Monte Carlo results that spanned the required range of radial distances and angles and had sufficiently fine spacing to make the interpolation between points accurate. Also Monte Carlo study considers the beta particles and electrons emitted by the source.
Other application of Monte Carlo
The Monte Carlo dose calculations are mostly used to obtain the dosimetric parameters around the brachytherapy sources to use in treatment planning systems. Calculated data provide the specific dose distributions based upon the actual locations of the sources in and around the patient; and also as a benchmarking tool for treatment planning systems (Williamson et al., 1999; Anagnostopoulos et al. 2003) . The main goal of clinical treatment planning is to find the best way to maximize the tumor dose and minimize the dose to the healthy tissue. Most current commercial treatment planning systems implemented the TG-43 formalism and the recommended dosimetry parameters in their systems to determine the dose distributions. Monte Carlo calculations can obtain the approximations in the calculations done by the treatment planning system. For low-energy sources, a major problem is characterizing tissue heterogeneities, requires estimation of the photoelectric cross section as well as tissue density these can have significant errors near inhomogeneities in the patient. Monte Carlo dose calculations can account for tissue-composition heterogeneities (Chibani and Williamson, 2005; Devic et al. 2000) . Monte Carlo dose calculations, when carefully validated against measurements, provide the highest level of accuracy for dose calculation in treatment planning, in situations where measurements are difficult or even impossible. Monte Carlo also can use for study and design of applicators. Intracavitary brachytherapy is mostly used for cancers of the cervix, uterine and vagina. Several rigid applicators have been used for intracavitary brachytherapy but it requires careful design of the applicators and precise placement of the sources with respect to the tumor volume and surrounding organs. The most clinical complication of intracavity brachytherapy in this case results from the high dose delivered to the critical surrounding organs such as bladder and rectum. Because the common types of source for treatment of gynecology are high energy sources, 137 Cs and 192 Ir. Monte Carlo simulation can play an important role to keep the dose to these critical organs as low as possible by obtain the dose rate in interest points. Another use of Monte Carlo in brachytherapy is its application in design of eye plaque. Radioactive eye plaque therapy is incorporating the use of radioactive seeds in a widely used technique for the treatment of ocular tumors. Monte Carlo simulation is performed to fully model the brachytherapy seeds loaded in the eye plaque to obtain the dose distribution in critical ocular structure and central axis of plaque. Brachytherapy seeds are placed in slots within a polymer carrier, Monte Carlo is possible to obtain the attenuation effect of the plaque backing, most often made of gold or stainless steel, and polymer carrier (Acrylic or Silastic) on dose distribution. Physical characteristics of photons emitted by different seed models (position, energy, location, and direction) are strongly dependent on seed construction, especially since brachytherapy sources are often constructed of high atomic number materials. In some cases, due to the presence of seed carrier inside the plaque the emitted photons from sources attenuate, thus more per seed is needed to deliver the prescription dose to the tumor volume, that can be obtained by Monte Carlo simulation. For example Granero et al., 2004 calculated the dose rate around the eye plaque loaded with 125 I sources in Acrylic insert and they found Acrylic insert has no attenuation effect on dose rate and the presence of acrylic insert can be negligible in the calculations. In other Mont Carlo simulations Chiu-Tsao et al., 1993, obtained 10% dose reduction at 1cm for Silastic insert; Thomson et al., 2008 reported 17% dose reduction for 103 Pd seed at distance of 1 cm in eye plaque due to presence of Silastic insert; and also calculated results by (Melhus & Rivard, 2008 ) demonstrated approximately 22.6%±0.5%, 13.0%±0.3%, and 10.8%±0.3% more in each 103 Pd, 125 I, and 131 Cs seed contained in a eye plaque, respectively was required to deliver the same dose to the apex of tumor. According to the Monte Carlo calculated data, size, shape and location of the eye tumor, standard eye plaque should design. Iodine-125 is currently the most commonly used source for radioactive eye plaque therapy. Few centers use palladium-103, and available reports indicate that because of its low energy emissions 20 keV which allow for a rapid decrease in dose with distance; and also, the short half-life, 17 days, result in higher dose rates and favorable dose distribution (Finger et al., 1999; Hall et al. 1991; Finger et al., 1991; Sadeghi & Hosseini, 2010) . Generally for the Monte Carlo simulation, the eye plaque is centered in a 15 cm radius water phantom to provide adequate photon backscatter and large enough to consider all the scattering effects of the surrounding medium. The Monte Carlo simulations provide the dose in a voxel per history. The dose rate is calculated by dividing this number by the air kerma strength per history for the relevant seed type and multiplying by the number of seeds and the air kerma strength per seed:
Where , , is the dose rate at the position x,y,z to deliver the prescription dose; , , is the dose rate per starting particle at position x,y,z; is the per source needed to deliver , , ; is the ratio of the and activity A(mCi) for a given source; K is the photons emitted per unit activity and n is the number of sources. Finally the total dose is calculated by integration , , over the prescribed treatment time. According to American Brachytherapy Society recommendation for uveal melanoma the prescription treatment time is 3 to 7 consecutive days to deliver a total prescription dose. The prescription dose depends on the prescription point, method of dose prescription and dosimetry calculation assumption but following the Collaborative Ocular Melanoma Study (COMS) group dosimetry calculation assumption, is 85 Gray to the tumor apex (Nag et al., 2003; Baltimore 1995; Melia et al., 2001; Granero et al., 2010) . In fact Monte Carlo Calculated dose rate for the eye plaque at interested point in the eye region has helped design of eye plaque as a valuable brachytherapy dosimetry tool.
Example of Monte Carlo calculations for dosimetric parameters of 103 Pd brachytherapy seed
This example presents Monte Carlo (MC) simulation results for the dosimetry parameters of the IR-103 Pd seed (Saidi et al., 2010) . Dose distributions in this example were simulated with the MCNP5 Monte Carlo (MC) radiation transport code published by Los Alamos National Laboratory (mcnpgreen.lanl.gov/index.html., 2008) and the MCPLIB04 photon cross-section library is based on the ENDF/B-VI data (BNL. NCS-17541, 8th ed., 2000) . In the calculations, the titanium characteristic X-ray production were suppressed with =5 keV ( is the energy cutoff) (Nath et al., 1995) . The spherical water phantom was modeled with a 30 cm diameter with an atomic ratio of 2:1 for H:O and =0.998 g/cm3. The seed source placed in the center of the phantom for the calculation of all dosimetric parameters at radial distances of r= 0.25, 0.5, 0.75, 1, 2, 3, 4, 5 and 7 cm, away from the source and at polar angles relative to the seed longitudinal axis from 0° to 180° with 10° increment. To validate the Monte Carlo simulation, results were compared by experimental values . The simulations were performed up to 1.1 × 10 9 histories. With this number of histories, statistical uncertainty for the source along the longitudinal axis at r ≤ 5 cm is lower than 1.3%, at 7 cm is 4.5% and at other angles it is between 0.04% and 0.1%. In air, with 1.5 × 10 8 histories, statistical uncertainty is 0.1%. Figure 2(a) , shows a schematic diagram of the IR-103 Pd seed. The seed contains five resin beads, which are packed inside a titanium cylinder of 4.8 mm length, 0.7 and 0.8 mm internal and external diameter respectively, and with an effective length of 3 mm. 103 Pd radioactive material is absorbed uniformly in the resin bead volume. As the beads are free to move within the titanium capsule, their location can vary with seed orientations. Saidi et al. (2010) , simulated three geometric models of the seed, ideal, vertical and diagonal, as shown in Figure 2 The dose rate constant for the 103 Pd seed was calculated by using the Equation (3). Due to the low energy of the photons from 103 Pd, it was assumed in the Monte Carlo calculations all electrons generated by the photon collisions are absorbed locally, so dose is equal to kerma at all points of interest (Sadeghi et al., 2008b) . The air-kerma rate of the IR-103 Pd seed in this example was estimated by calculating the dose in 1 mm-thick air-filled rings in a vacuum.
The rings were bounded by 86° and 94° conics and defined with a radial increment of 5 cm to 150 cm along the transverse axis of the source and also the MCNP F6 tally, was used for calculate the dose distribution around the seed in each of the three orientations consider in this work. (Saidi et al., 2010) in ( Table 2 shows the calculated dose rate constant for the IR-103 Pd seed (Saidi et al., 2010) , new 103 Pd source (Rivard et al., 2004b) and the calculated and measured values of Λ, for NASI model MED3633 and Theragenics model 200 sources (Rivard et al., 2004b) . The Monte Carlo calculated values of geometry function in this example for three orientations are shown in Table 3 (a), (c) and (d). They used the form, r 2 G(r,θ), instead of G(r,θ), for easier calculations and then normalized to G(1cm,π/2) for convenience to compare with other published data (Rivard, 2001; King et al., 2001) . The results were compared with Raisali et al., (2008) data. The calculated line and point source radial dose function for the ideal orientation of the IR-103 Pd seed in Perspex and water in this example and those determined from calculated and measurement by are presented in Table 4 . Figure 3 shows Raisali et al., (2008) in Perspex and also calculated in water. (Saidi et al., 2010) with the MED3633 and Theragenics model 200 sources (Rivard et al., 2004a) at the distance of 5 cm.
The anisotropy function, F(r,θ), of the IR-103 Pd seed was calculated in Perspex phantom at radial distances of r = 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5and 7 cm relative to the seed center and polar angle, θ ranging from 0° to 90° for ideal orientation and 0° to 180° for vertical and diagonal orientations in 10° increment with respect to the seed long axis. Saidi et al.'s (2010) results are shown in Table 5 and in compared with the measured data by Raisali et al., (2010) , for ideal orientation. The data are shown graphically at distances of 2, 3 and 5 cm in Figure 4 . Figure 5 shows a comparison of the anisotropy function at r = 5 cm of the IR-103 Pd with MED3633 and Theragenics model 200 sources. Table 5 . 2D anisotropy functions for the IR-103 Pd seed calculated by Monte Carlo method (Saidi et al., 2010) for the (a) ideal orientation, (b) vertical orientation, (c) diagonal orientation. This volume is an eclectic mix of applications of Monte Carlo methods in many fields of research should not be surprising, because of the ubiquitous use of these methods in many fields of human endeavor. In an attempt to focus attention on a manageable set of applications, the main thrust of this book is to emphasize applications of Monte Carlo simulation methods in biology and medicine.
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